搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按相关度排序
按时间排序
labiotech
1 天
From consumer health to pure biopharma: Inside Sanofi’s strategic shift
In October 2023, Sanofi announced plans to separate its consumer health unit in 2024. Sanofi’s consumer health division, with ...
labiotech
1 天
Top biotech deals of October 2024
Discover the major biotech partnerships, collaborations, and mergers and acquisitions that made headlines in October 2024.
labiotech
1 天
Unlocking AAV gene therapy potential: The role of successful characterization
Explore the role and challenges of AAV characterization, the significance of capsid filling, and the best methods to enhance gene therapy.
labiotech
4 天
Can AI cure Alzheimer’s disease?
Find out what AI has already brought to Alzheimer's disease research and most importantly, what it can accomplish in the ...
labiotech
6 天
Five T cell engager companies you should know about
Discover five T cell engager companies that have emerged in recent times, as this class of therapeutics is set to take off.
labiotech
7 天
GPCR therapies: Eight promising biotechs hacking the cell signaling pathway
In this article, we take a look at eight biotechs that have acquired funding in recent years to fortify their GPCR-focused ...
labiotech
5 天
Halloween biotech stories: Unveiling scientists’ worst fears
What are scientists scared of? Delve into three biotech sci-fi-inspired scenarios that might make you fear progress.
labiotech
6 天
Spatial Transcriptomics: A window into disease
The emerging spatial transcriptomics field is letting researchers map out gene expression in tumor and brain samples. How ...
labiotech
13 天
Top biotech associations around the world
Discover top biotech associations that drive industry growth through collaboration, networking, and strategic partnerships ...
labiotech
12 天
Fighting severe epilepsies: A new era for Dravet syndrome treatment?
Delve into the field of severe epilepsies as new treatments for Dravet syndrome are progressing through the pipeline.
labiotech
13 天
Six biotech companies advancing multiple sclerosis therapies
Take a look at six multiple sclerosis companies trying to make a difference to patients by advancing new treatments for the ...
labiotech
7 天
Could next-generation “switchable” CAR-T cells help improve the safety and efficacy of ...
Discover how next-generation "switchable" CAR-T cells could improve both the safety and efficacy of CAR-T therapies.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈